Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet ...

Stephen Lankenau has spent years studying how people use cannabis in everyday life. As director of Drexel University’s ...

Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, ...

Collaboration report an individual participant data meta-analysis of double-blind randomised controlled trials (RCTs) assessing whether adverse outcomes listed in statin product labels are causally ...

The US Food and Drug Administration (FDA) has revised a 2023 draft guidance on master protocols for drug and biological ...

Vivani CEO Adam Mendelsohn, Ph.D., stated, “HREC approval to initiate SLIM-1 in Australia marks an important moment for our Company, clearing the way for near-term, mid-2026, initiation. We are eager ...

Researchers tested the oral GLP-1 drug aleniglipron in a phase 2 trial. Participants on the highest dose lost ~12% body ...

The largest-ever U.K. trial of a urine test used across the NHS to spot when patients skip their medication has shown it may improve adherence to treatment. Led by researchers at the University of ...

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and published in The Lancet Psychiatry has found that people with psychosis experiencing Post ...

Recent research has overturned the idea that self-critical behavior fosters resilience. An innovative study demonstrated that ...

GLP-1 drugs male fertility research presented at ENDO 2026 finds Ozempic-class medications do not harm male hormones and may ...

The first patient was treated at Monash Health in Clayton, Victoria, Australia, with other trial sites planned in the near ...